Pathophysiology of perinatal hypoxic-ischemic encephalopathy – biomarkers, animal models and treatment perspectives

0470156 - FGÚ 2017 RIV CZ eng J - Článek v odborném periodiku
Riljak, V. - Kraf, J. - Daryanani, A. - Jiruška, Přemysl - Otáhal, Jakub
Pathophysiology of perinatal hypoxic-ischemic encephalopathy – biomarkers, animal models and treatment perspectives.
Physiological Research. Roč. 65, Suppl.5 (2016), S533-S545. ISSN 0862-8408. E-ISSN 1802-9973
Grant CEP: GA MZd(CZ) NV15-33115A; GA ČR(CZ) GA15-08565S; GA ČR(CZ) GA14-02634S; GA MŠMT LM2015062
Institucionální podpora: RVO:67985823
Klíčová slova: hypoxic-ischemic encephalopathy * excitotoxicity * oxidative stress * inflammation * biomarkers
Kód oboru RIV: FH - Neurologie, neurochirurgie, neurovědy
Impakt faktor: 1.461, rok: 2016

Hypoxic-ischemic encephalopathy (HIE) is one of the leading pediatric neurological conditions causing long-term disabilities and socio-economical burdens. Nearly 20-50 % of asphyxiated newborns with HIE die within the newborn period and another third will develop severe health consequences and permanent handicaps. HIE is the result of severe systemic oxygen deprivation and reduced cerebral blood flow, commonly occurring in full-term infants. Hypoxic-ischemic changes trigger several molecular and cellular processes leading to cell death and inflammation. Generated reactive oxygen species attack surrounding cellular components resulting in functional deficits and mitochondrial dysfunction. The aim of the present paper is to review present knowledge about the pathophysiology of perinatal hypoxic-ischemic encephalopathy, especially with respect to novel treatment strategies and biomarkers that might enhance early detection of this disorder and thus improve the general outcome of patients.
Trvalý link: http://hdl.handle.net/11104/0267871